Kaleido Biosciences, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
KLDO on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
18 Crosby Drive, Bedford, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Kaleido Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bonnie L. Bassler Director Jun 30, 2021
William E. Duke Chief Financial Officer Jan 14, 2022
Johan van Hylckama Chief Scientific Officer Feb 28, 2022
Geoffrey von Maltzahn Director Jun 30, 2021
Grady Burnett Director Jun 30, 2021
Alison S. Long Chief Medical Officer Jan 14, 2022
Michael W. Bonney Director Jun 30, 2021
Kyriazi Theo Melas Director Jun 30, 2021
Daniel L. Menichella Chief Executive Officer, Director Jan 14, 2022
Jean K. Mixer Director Jun 30, 2021
Jerald Korn COO & General Counsel Feb 28, 2022
Anne Prener Director Jun 30, 2021
Anthony G. Quinn Director Jun 30, 2021

Recent Insider Transactions by Companies or Individuals for Kaleido Biosciences, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership